Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Hair loss gene linked to prostate issues.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Finasteride treats hair loss but may affect prostate cancer detection.

New treatments for hair loss are being developed using molecular biology.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Some common medications can harm male fertility, but many effects can be reversed.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Minoxidil and finasteride combined can effectively treat hair loss.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

The normal human prostate does not significantly affect blood DHT levels.

Consider benefits and risks of new alopecia treatments for safety.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Physical activity, height, and smoking affect prostate cancer risk.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.